These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28705450)

  • 1. Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
    Machado AS; Oliveira MS; Sanches C; Silva Junior CVD; Gomez DS; Gemperli R; Santos SRCJ; Levin AS
    Clin Ther; 2017 Aug; 39(8):1649-1657.e3. PubMed ID: 28705450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
    Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection in burn patients in a referral center in Colombia.
    Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
    Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial infection characteristics in a burn intensive care unit: analysis of an eleven-year active surveillance.
    Öncül O; Öksüz S; Acar A; Ülkür E; Turhan V; Uygur F; Ulçay A; Erdem H; Özyurt M; Görenek L
    Burns; 2014 Aug; 40(5):835-41. PubMed ID: 24296064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are higher vancomycin doses needed in ventricle-external shunted patients?
    Pujal M; Soy D; Codina C; Ribas J
    Pharm World Sci; 2006 Aug; 28(4):215-21. PubMed ID: 17066239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of application of vancomycin in the early stage of patients with extremely severe burn].
    Zhu Z; Cao GW; Bao JJ; Hu ZH; Shen Z; Tao H; Cao B; Xu F
    Zhonghua Shao Shang Za Zhi; 2017 Apr; 33(4):206-210. PubMed ID: 28427133
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multidrug-resistant Acinetobacter Baumannii infection in Intensive Care Unit: A retrospective analysis].
    He L; Meng J; Huang D; Hu C; Pan P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 40(12):1327-32. PubMed ID: 26739074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.
    Youssif E; Aseeri M; Khoshhal S
    J Infect Public Health; 2018; 11(4):486-490. PubMed ID: 29153444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
    Dickstein Y; Leibovici L; Yahav D; Eliakim-Raz N; Daikos GL; Skiada A; Antoniadou A; Carmeli Y; Nutman A; Levi I; Adler A; Durante-Mangoni E; Andini R; Cavezza G; Mouton JW; Wijma RA; Theuretzbacher U; Friberg LE; Kristoffersson AN; Zusman O; Koppel F; Dishon Benattar Y; Altunin S; Paul M;
    BMJ Open; 2016 Apr; 6(4):e009956. PubMed ID: 27098822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and outcome analysis of burn patients admitted to an Intensive Care Unit in a University Hospital.
    Queiroz LF; Anami EH; Zampar EF; Tanita MT; Cardoso LT; Grion CM
    Burns; 2016 May; 42(3):655-62. PubMed ID: 26762620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors, Clinical Presentation, and Outcome of
    Ballouz T; Aridi J; Afif C; Irani J; Lakis C; Nasreddine R; Azar E
    Front Cell Infect Microbiol; 2017; 7():156. PubMed ID: 28523249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit.
    Fournier A; Eggimann P; Pantet O; Pagani JL; Dupuis-Lozeron E; Pannatier A; Sadeghipour F; Voirol P; Que YA
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
    Kielstein JT; Czock D; Schöpke T; Hafer C; Bode-Böger SM; Kuse E; Keller F; Fliser D
    Crit Care Med; 2006 Jan; 34(1):51-6. PubMed ID: 16374156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
    Lee HY; Chen CL; Wu SR; Huang CW; Chiu CH
    Crit Care Med; 2014 May; 42(5):1081-8. PubMed ID: 24394630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for multidrug-resistant Gram-negative infection in burn patients.
    Vickers ML; Dulhunty JM; Ballard E; Chapman P; Muller M; Roberts JA; Cotta MO
    ANZ J Surg; 2018 May; 88(5):480-485. PubMed ID: 28853230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.
    Lambert ML; Suetens C; Savey A; Palomar M; Hiesmayr M; Morales I; Agodi A; Frank U; Mertens K; Schumacher M; Wolkewitz M
    Lancet Infect Dis; 2011 Jan; 11(1):30-8. PubMed ID: 21126917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial infections and resistance pattern of common bacterial isolates in an intensive care unit of a tertiary hospital in Nigeria: A 4-year review.
    Iliyasu G; Daiyab FM; Tiamiyu AB; Abubakar S; Habib ZG; Sarki AM; Habib AG
    J Crit Care; 2016 Aug; 34():116-20. PubMed ID: 27288622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.